| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/21/2010 | EP1411900B1 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 07/21/2010 | EP1259243B2 Bupropion metabolites and methods of their synthesis and use |
| 07/21/2010 | EP1079825B1 Compounds that inhibit the binding of integrins to their receptors |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1960977B Quinazoline derivative |
| 07/21/2010 | CN1732946B Pharmaceutical composition for preventing and treating poultry ascites |
| 07/21/2010 | CN101784551A bicycloaniline derivative |
| 07/21/2010 | CN101781285A Quinazoline derivates, preparation method thereof and pharmaceutical application thereof |
| 07/21/2010 | CN101780286A Chemotactic factor receptor CXCR4 non-peptide antagonist medicaments for radiodiagnosis and treatment |
| 07/21/2010 | CN101780202A Body-fragrant medicament and preparation method thereof |
| 07/21/2010 | CN101780184A Application of nutrition combination in preparation of medicine for restoring mismatch repair gene damage |
| 07/21/2010 | CN101780182A Application of nutrition combination in preparation of medicine for restoring mitochondrial damage |
| 07/21/2010 | CN101780144A Formula and preparation method of moxa stick |
| 07/20/2010 | US7759526 Pharmaceutical compositions comprising cannabidiol derivatives |
| 07/20/2010 | US7759486 2,4,5-Trisubstituted pyrimidine compounds |
| 07/20/2010 | US7759476 Double-stranded RNAS directed to IKK-2 |
| 07/20/2010 | US7759463 RNA interference pathway genes as tools for targeted genetic interference |
| 07/20/2010 | US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 07/20/2010 | US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759379 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 07/20/2010 | US7759373 nitrogen-containing 5-membered heterocyclic compound |
| 07/20/2010 | US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
| 07/20/2010 | US7759364 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby |
| 07/20/2010 | US7759357 N-[4-3-chloro-phenyl)-pyrimidin-2-yl]-N-(4-trifluoromethyl-phenyl)-amine, having immunoglobulin E (IgE) synthesis inhibiting activity, used for treating rheumatoid arthritis |
| 07/20/2010 | US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 07/20/2010 | US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 07/20/2010 | US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus |
| 07/20/2010 | US7759326 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus |
| 07/20/2010 | US7759324 Antiadhesive carbohydrates |
| 07/20/2010 | US7759323 Highly purified antiendotoxin compound |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759083 Using thrombin-antithrombin III complex as tool in identifying modulators of glypican-3 expression; treating arteriosclerosis |
| 07/20/2010 | US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
| 07/20/2010 | CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 07/20/2010 | CA2447865C Novel sulfonic acid derivatives |
| 07/20/2010 | CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis |
| 07/20/2010 | CA2442415C Medical aerosol formulations |
| 07/20/2010 | CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/20/2010 | CA2411831C Pharmaceutical compositions comprising cannabidiol derivatives |
| 07/20/2010 | CA2399001C Integrin expression inhibitor |
| 07/20/2010 | CA2340931C 3'-deoxypentopyranosylnucleic acid, its preparation and use |
| 07/20/2010 | CA2322487C Novel prodrugs for phosphorus-containing compounds |
| 07/20/2010 | CA2288983C Covalently linked n,o-carboxymethylchitosan and uses thereof |
| 07/20/2010 | CA2287819C Shampoo composition comprising a lipophilic polysiloxane type uv-b screening agent |
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/20/2010 | CA2191063C Dna encoding glutamate gated chloride channels |
| 07/20/2010 | CA2105449C An interferon-.alpha./.beta. binding protein, its preparation and pharmaceutical compositions containing it |
| 07/15/2010 | WO2010080720A2 Conjugates of a lysosomal enzyme moiety and a water soluble polymer |
| 07/15/2010 | WO2010079833A1 Novel cancer antigen eef2 |
| 07/15/2010 | WO2010079819A1 Pharmaceutical composition for treating obesity or diabetes |
| 07/15/2010 | WO2010079668A1 Olefin compound |
| 07/15/2010 | WO2010079255A1 Use of inverse antagonists and/or agonists of cb1 receptors for preparing drugs to increase motor neurone excitability |
| 07/15/2010 | WO2010078730A1 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection |
| 07/15/2010 | US20100179229 Method for modulating the taste of material compositions containing at least one high intensity sweetener (his) |
| 07/15/2010 | US20100179212 Pharmaceutical composition which improves in vivo gene transfer |
| 07/15/2010 | US20100179200 2-oxothiazolidine 4-carboxylic acid compounds for promoting desquamation of the skin |
| 07/15/2010 | US20100179190 Bicyclic pyrazolo protein kinase modulators |
| 07/15/2010 | US20100179180 Crystalline irinotecan hydrochloride and methods for its preparation |
| 07/15/2010 | US20100179096 Methods of treating fibrosing diseases by induction of immune tolerance |
| 07/15/2010 | US20100179095 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 07/15/2010 | US20100179092 Human complement c3 derivatives with cobra venom factor-like function |
| 07/15/2010 | US20100179091 Treatment of Conditions Related to Shock |
| 07/15/2010 | US20100178354 Remedy |
| 07/15/2010 | US20100178350 Amino-acid-containing medicinal granular preparation highly easy to take |
| 07/15/2010 | US20100178332 Cellulose-based fine core particle and process for producing the same |
| 07/15/2010 | US20100178322 Adhesive preparation and patch preparation |
| 07/15/2010 | US20100178313 Implantable Degradable Biopolymer Fiber Devices |
| 07/15/2010 | US20100178304 Method for silk fibroin gelation using sonication |
| 07/15/2010 | US20100178279 Beta-Glucan Enhances Hematopoietic Progenitor Cells Engraftment and Promotes Recovery from Chemotoxicity |
| 07/15/2010 | US20100178278 Formable bioceramics |
| 07/15/2010 | US20100178254 Unit assembly for multiple film dosages, apparatus, and methods |
| 07/15/2010 | US20100178251 Dual-Sensitizer-Containing Luminescent Compounds, Conjugates, and Uses Thereof |
| 07/15/2010 | US20100178248 Use of phenyloxyaniline derivatives for imaging cardiovascular diseases |
| 07/15/2010 | US20100178243 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/14/2010 | EP2206773A1 Espansion of renewable stem cell populations |
| 07/14/2010 | EP2206772A2 Method of collecting placental stem cells |
| 07/14/2010 | EP2206729A1 Antibodies for identifiying and/or isolating at least one cell population which is selected from the group comprising haematopoietic stem cells, neuronal stem cells, neuronal precursor cells, mesenchymal stem cells and mesenchymal precursor cells |
| 07/14/2010 | EP2206725A1 Analogs of parathyroid hormone |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206715A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor |
| 07/14/2010 | EP2206707A1 Azolecarboxamide compound or salt thereof |
| 07/14/2010 | EP2206702A1 Bicyclic compound, production and use thereof |
| 07/14/2010 | EP2206534A1 Dibenzocycloheptanone derivatives und pharmaceutical agents containing these compounds |
| 07/14/2010 | EP2206533A2 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene hydrazino -2'-hydroxy- 1,1'-biphenyl -3-carboxylic acid bis-(monoethanolamine) |
| 07/14/2010 | EP2206518A1 Pharmaceutical composition containing lipophilic il-2 production inhibitor |
| 07/14/2010 | EP2206502A1 Polymer conjugate of steroid |
| 07/14/2010 | EP2205276A2 Anti-il-12/23p40 antibodies, epitopes, formulations, compositions, methods and uses |
| 07/14/2010 | EP1514116B9 Oxaliplatin anti-resistance method |
| 07/14/2010 | EP1513859B1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 07/14/2010 | EP1490030B2 Nanoparticulate compositions of angiogenesis inhibitors |
| 07/14/2010 | EP1486494B1 N-substituted benzothiophenesulfonamide derivative |
| 07/14/2010 | EP1278824B1 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus |
| 07/14/2010 | EP1220684B2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/14/2010 | CN101778641A Preventive/remedy for cancer |
| 07/14/2010 | CN101775008A Antidiabetic compound, preparation method and application thereof |
| 07/14/2010 | CN101773669A HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/14/2010 | CN101773622A Chinese medicinal composition for treating night sweats and preparation method thereof |